The sentinel node biopsy in patients with breast cancer; many controversies remain

The sentinel node procedure has increasingly been used as a diagnostic tool for staging breast cancer. Although many institutes have embraced this procedure, many issues concerning the indications and the technique itself remain unsolved. In this review, several aspects regarding these controversies are discussed from the perspective of The Netherlands Cancer Institute. These include the definitions used to identify the sentinel node, the indications and contraindications for this procedure and the injection site of the tracer and blue dye. What are the clinical implications of a micro-metastasis in the sentinel node? What is the best treatment for patients with an involved axillary node? Should non-axillary sentinel nodes be pursued, and if so, what are the implications for further management of these patients? Finally, the current TNM system is discussed in perspective of the evolving sentinel node procedure. Although many questions remain to be solved, the regional recurrence rates are low when axillary clearance is omitted because of a tumor-free sentinel node.

Breast neoplasms; Lymphatic metastasis; Sentinel lymph node biopsy

[1] Morton D.L., Wen D.R., Wong J.H. et al.: "Technical details of intraoperative lymphatic mapping for early stage melanoma". Arch. Surg., 1992, 127, 392.

[2] Cabanas R.M.: "An approach for the treatment of penile carcinoma". Cancer, 1977, 39, 456.

[3] Perinetti E., Crane D.B., Catalona W.J.: "Unreliability of sentinel lymph node biopsy for staging penile carcinoma". J. Ural., 1980, 124, 734.

[4] Naruke T., Tsuchiya R., Kondo H. et al.: "Lymph node sampling in lung cancer: how should it be done?". Eur. J. Cardiothorac. Surg., 1999, 16 (suppl. I), S17.

[5] Wiese D.A., Saha S., Badin J. et al.: "Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma". Arch. Pathol. Lab. Med., 2000, 124, 1759.

[6] Nieweg O.E., Tanis P.J., Kroon B.B.: "The definition of a sentinel node". Ann. Surg. Oneal., 2001, 8, 538.

[7] Veronesi U., Paganelli G., Galimberti V. et al.: "Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes". Lancet, 1997, 349, 1864.

[8] Boxen I., Mccready D., Ballinger J.R.: "Sentinel node detection and definition may depend on the imaging agent and timing". Clin. Nucl. Med., 1999, 24, 390.

[9] Sener S.F., Winchester D.J., Brinkmann E. et al.: "Failure of sentinel lymph node mapping in patients with breast cancer". J. Am. Coll. Surg., 2004, 198, 732.

[10] Wong S.L., Edwards M.J., Chao C. et al.: "The effect of lymphatic tumor burden on sentinel lymph node biopsy results". Breast J., 2002, 8, 192.

[11] Vargas H.I.,V argas M.P.,V enegas R. et al.: "Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer". Am. Surg., 2003, 69, 886.

[12] Tanis P.J., van Sandick J.W., Nieweg O.E. et al.: "The hidden sentinel node in breast cancer". Eur. J. Nucl. Med. Mal. Imaging, 2002, 29, 305.

[13] Taylor A. Jr., Murray D.R., Herda S.C. et al.: "Dynamic lymphoscintigraphy to identify the sentinel and satellite nodes". Clin. Nucl. Med., 1996, 21, 755.

[14] McMasters K.M., Noyes R.D., Reintgen D.S. et al.: "Lessons learned from the Sunbelt Melanoma Trial". J. Surg. Oneal., 2004, 86, 212.

[15] Fisher B., Wolmark N., Bauer M. et al.: "The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast". Surg. Gynecol. Obstet., 1981, 152, 765.

[16] Cutler S.J., Axtell L.M., Schottenfeld D. et al.: "Clinical assessment of lymph nodes in carcinoma of the breast". Surg. Gynecol. Obstet., 1970, 131, 41.

[17] Specht M.C., Fey J.V., Borgen P.I. et al.: "Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?". J. Am. Coll. Surg., 2005, 200, 10.

[18] Deurloo E.E., Tanis P.J., Gilhuijs K.G. et al.: "Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer". Eur. J. Cancer, 2003, 39, 1068.

[19] Bonnema J., Van Geel A.N., van Ooijen B. et al.: "Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method". World J. Surg., 1997, 21, 270.

[20] De Kanter A.Y., Van Eijck C.H.J., Van Geel A.N. et al.: "Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer". Br. J. Surg., 1999, 86, 1459.

[21] Kuenen-Boumeester V., Menke-Pluymers M., De Kanter A.Y. et al.: "Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure". Eur. J. Cancer, 2003, 39, 170.

[22] Brenot-Rossi I., Houvenaeghel G., Jacquemier J. et al.: "Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there apathologic significance in breast cancer?". J. Nucl. Med., 2003, 44, 1232.

[23] Martin R.C., Fey J., Yeung H. et al.: "Highest isotope count does not predict sentinel node positivity in all breast cancer patients". Ann. Surg. Oneal., 2001, 8, 592.

[24] Camp E.R., Cendan J.C., Feezor R. et al.: "The hottest sentinel lymph node is not always the positive node". Am. Surg., 2004, 70, 475.

[25] Ozmen V., Muslumanoglu M., Cabioglu N. et al.: "Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer". Breast Cancer Res. Treat., 2002, 76, 237.

[26] Tousimis E., Van Zee K.J., Fey J.V. et al.:" The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers". J. Am. Coll. Surg., 2003, 197, 529.

[27] Veronesi U., Paganelli G., Viale G. et al.: "Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series". J. Natl Cancer Inst., 1999, 91, 368.

[28] Bauer T.W., Spitz F.R., Callans L.S. et al.: "Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer". Ann. Surg. Oneal., 2002, 9, 169.

[29] Trisal V., Qian D., Wagman L.D.: "Axillary recurrence in DCis: is axillary lymphadenectomy warranted?". Am. Surg., 2004, 70, 876.

[30] Jakub J.W., Pendas S., Reintgen D.S.: "Current status of sentinel lymph node mapping and biopsy: facts and controversies". Oncologist, 2003, 8, 59.

[31] Cox C.E., Nguyen K., Gray R.J. et al.: "Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?". Am. Surg., 2001, 67, 513.

[32] Pendas S., Dauway E., Giuliano R. et al.: "Sentinel node biopsy in ductal carcinoma in situ patients". Ann. Surg. Oncol., 2000, 7, 15.

[33] Lara J.F., Young S.M., Velilla R.E. et al.: "The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up". Cancer, 2003, 98, 2105.

[34] Kang S.H., Kim S.K., Kwon Y. et al.: "Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy". World J. Surg., 2004, 28, 1019.

[35] Noguchi M.: "Current controversies concerning sentinel lymph node biopsy for breast cancer". Breast Cancer Res Treat., 2004, 84, 261.

[36] Shimazu K., Tamaki Y., Taguchi T. et al.: "Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma". Cancer, 2004, 100, 2555.

[37] Wong S.L., Edwards M.J., Chao C. et al.: "The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy". Ann. Surg. Oneal., 2002, 9, 272.

[38] Haigh P.l., Hansen N.M., Qi K. et al.: "Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer". Ann. Surg. Oneal., 2000, 7, 21.

[39] Estourgie S.H., Valdes Olmos R.A., Nieweg 0.E. et al.: "Reproducibility of sentinel node lymphoscintigraphy after excisional biopsy of breast lesions". Annual Congress of the European Association of Nuclear Medicine, 2004.

[40] Nieweg O.E., Estourgie S.H., van Rijk M.C. et al.: "Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients". J. Surg. Oneal., 2004, 87, 153.

[41] Chagpar A., Martin R.C. III, Chao C. et al.: "Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy". Arch. Surg., 2004, 139, 614.

[42] Eroglu A., Mudun A., Berberoglu K. et al: "Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer". Clin. Nucl. Med., 2004, 29, 306.

[43] Beitsch P.D., Clifford E., Whitworth P. et al.: "Improved lymphatic mapping technique for breast cancer". Breast J., 2001, 7, 219.

[44] Rubello D., Zavagno G., Bozza F. et al.: "Analysis of technical and clinical variables affecting sentinel node localization in patients with breast cancer after a single intradermal injection of 99mTc nanocolloidal albumin". Nucl. Med. Commun., 2004, 25, 1119.

[45] Canavese G., Gipponi M., Catturich A. et al.: "Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients". J. Surg. Oneal., 2000, 74, 69.

[46] Krynyckyi B.R., Chun H., Kim H.H. et al.: "Factors affecting visualization rates of internal mammary sentinel nodes during lymphoscintigraphy". J. Nucl. Med., 2003, 44, 1387.

[47] Estourgie S.H., Nieweg O.E., Valdes Olmos R.A. et al.: "Intratumoral versus intraparenchymal injection technique for lymphoscintigraphy in breast cancer". Clin. Nucl. Med., 2003, 28, 371.

[48] Shen P., Glass E.C., Difronzo L.A. et al.: "Dermal versus intra-parenchymal lymphoscintigraphy of the breast". 53" Annual Cancer Symposium Soc. Surg. Oncol., 2000, 13.

[49] Paganelli G., Galimberti V., Trifiro G. et al.: "Internal mammary node lymphoscintigraphy and biopsy in breast cancer". Q.J. Nucl. Med., 2002, 46, 138.

[50] Tanis P.J., Deurloo E.E., Valdes Olmos R.A. et al.: "Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node". Ann. Surg. Oneal., 2001, 8, 850.

[51] Rutgers E.J.: "Sentinel node micrometastasis in breast cancer". Br. J. Surg., 2004, 91, 1241.

[52] Csemi G., Gregori D., Merletti F. et al.: "Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer". Br. J. Surg., 2004, 91, 1245.

[53] Weiser M.R., Montgomery L.L., Susnik B. et al.: "Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?". Ann. Surg. Oneal., 2000, 7, 651.

[54] Hwang R.F., Krishnamurthy S., Hunt K.K. et al.: "Clinicopathologic factors predicting involvement of nonsentinel axillary nodes m women with breast cancer". Ann. Surg. Oneal., 2003, 10, 248.

[55] Degnim A.C., Griffith K.A., Sabel M.S. et al.: "Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients". Cancer, 2003, 98, 2307.

[56] Viale G., Maiorano E., Mazzarol G. et al.: "Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma". Cancer, 2001, 92, 1378.

[57] Joseph K.A., El Tamer M., Komenaka I. et al.: "Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis". Arch. Surg., 2004, 139, 648.

[58] Reynolds C., Mick R., Donohue J.H. et al.: "Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?". J. Clin. Oneal., 1999, 17, 1720.

[59] Gray R.J., Pockaj B.A., Conley C.R.: "Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer". Ann. Surg. Oneal., 2004, 11, 1056.

[60] Bader A.A., Tio J., Petru E. et al.: "T l breast cancer: identification of patients at low risk of axillary lymph node metastases". Breast Cancer Res. Treat., 2002, 76, 11.

[61] Weiser M.R., Montgomery L.L., Tan L.K. et al.: "Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes". Ann. Surg. Oneal., 2001, 8, 145.

[62] Gerber B., Krause A., Muller H. et al.: "Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow asptrates in breast cancer and its correlation with other prognostic factors". J. Clin. Oneal., 2001, 19, 960.

[63] Cote R.J., Peterson H.F., Chaiwun B. et al.: "Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group". Lancet, 1999, 354, 896.

[64] Susnik B., Frkovic-Grazio S., Bracko M.: "Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in Stage I breast cancer: a case-control study with 15-year follow-up". Ann. Surg. Oneal., 2004, 11, 568.

[65] Millis R.R., Springall R., Lee A.H. et al.: "Occult axillary lymph node metastases are of no prognostic significance in breast cancer". Br. J. Cancer, 2002, 86, 396

[66] Colpaert C., Vermeulen P., Jeuris W. et al.: "Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour". J. Pathol., 2001, 193, 442.

[67] Tjan-Heijnen V.C., Buit P., Widt-Evert L.M. et al.: "Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure". Breast Cancer Res. Treat., 2001, 70, 81.

[68] The Breast, Comprehensive Management of Benign and Malignant Disorders, 3''edition, Missouri, Saunders, 2004.

[69] Estourgie S.H., Nieweg O.E., Valdes Olmos R.A. et al.: "Lymphatic drainage patterns from the breast". Ann. Surg. Oneal., 2003,10, S54.

[70] Chandawarkar R.Y., Shinde S.R.: "Interpectoral nodes in carcinoma of the breast: requiem or resurrection". J. Surg. Oneal., 1996, 62, 158.

[71] Bale A., Gardner B., Shende M. et al.: "Can interpectoral nodes be sentinel nodes?". Am. J. Surg., 1999, 178, 360.

[72] Dixon J.M., Dobie V., Chetty U.: "The importance of interpectoral nodes in breast cancer". Eur. J. Cancer, 1993, 29A, 334.

[73] Komenaka I.K., Bauer V.P., Schnabel F.R. et al.: "Interpectoral nodes as the initial site of recurrence in breast cancer". Arch. Surg., 2004, 139, 175.

[74] Barranger E., Montravers F., Kerrou K. et al.: "Contralateral axillary sentinel lymph node drainage in breast cancer: A case report". J. Surg. Oneal., 2004, 86, 167.

[75] Arriagada R., Le M.G., Mouriesse H. et al.: "Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes". Radiother. Oneal., 1988, 11,213.

[76] Veronesi U., Cascinelli N., Greco M. et al.: "Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes" Ann. Surg., 1985, 202, 702.

[77] Noguchi M.,O hta N., Thomas M.: "Risk of internal mammary lymph node metastases and its prognositc value in breast cancer patients" J. Surg. Oncol., 1993, 52, 26.

[78] Noguchi M., Taniya T., Koyasaki N. et al.: "A multivariate study of the relationship between regional lymph node metastases and prognosis in patients with operable breast cancer". Jpn. J. Surg., 1991, 21, 613.

[79] Shen J., Hunt K.K., Mirza N.Q. et al.: "Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma". Cancer, 2004, 101, 1330.

[80] Stemmer S.M., Rizel S., Hardan I. et al.: "The role of irradiation of the internal mammary lymph nodes in high-risk Stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study". J. Clin. Oncol., 2003, 21, 2713.

[81] Fowble B., Hanlon A., Freedman G. et al.: "Internal mammary node irradiation neither decreases distant metastases nor improves survival in Stage I and II breast cancer". Int. J. Radial. Oneal. Biol. Phys., 2000, 47, 883.

[82] van Rijk M.C., Tanis P.J., Valdes Olmos R.A. et al.: "Sentinel Nodes outised the axilla and internal mammary chain in patients with breast cancer". Eur. J. Nucl. Med. Mal. Imaging, 2004 (suppl. 2), S196.

[83] Tanis P.J., Nieweg O.E., Valdes Olmos R.A. et al.: "Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients". Br. J. Cancer, 2002, 87, 705.

[84] Estourgie S.H., Nieweg O.E., Valdes Olmos R.A. et al.: "Should the hunt for internal mammary chain sentinel nodes begin?". Ann. Surg. Oneal., 2003, 10, S25.

[85] Fujimoto N., Amemiya A., Kondo M. et al.: "Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes usmg radiotherapy versus axillary dissection". Cancer, 2004, 101, 2155.

[86] Louis-Sylvestre C., Clough K., Asselain B. et al.: "Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up". J. Clin. Oneal., 2004, 22, 97.

[87] Hoebers F.J., Borger J.H., Hart A.A. et al.: "Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes". Cancer, 2000, 88, 1633.

[88] Rutgers E.J., Meijnen P., Bonnefoi H.: "Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group". Breast Cancer Res., 2004, 6, 165.

[89] Rutgers E.J.: "Sentinel node procedure in breast carcinoma: a valid tool to omit unnecessary axillary treatment or even more?". Eur. J. Cancer, 2004, 40, 182.

[90] Nieweg O.E., Bartelink H.: "Implications of lymphatic mapping for staging and adjuvant treatment of patients with breast cancer". Eur. J. Cancer, 2004, 40, 179.

[91] Clare S.E., Sener S.F., Wilkens W. et al.: "Prognostic significance of occult lymph node metastases in node-negative breast cancer". Ann. Surg Oneal., 1997, 4, 447.

[92] Colleoni M., Rotmensz N., Peruzzotti G. et al.: "Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement". J. Clin. Oncol., 2005, 23, 1379.